logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Osaka University Hospital

+81668795111
sisetu-seibi-kenkei@office.osaka-u.ac.jp
Source: Site record.
https://www.hosp.med.osaka-u.ac.jp

Claim This Site

Are you the site administrator? Claim this site to update information.

Source: Trial-derived.
249Total Trials
Source: Trial-derived.
60Recruiting Trials
Source: Trial-derived.
128Active Trials
Source: Trial-derived.
92Completed Trials
Source: Trial-derived.
302Unique Conditions
Source: Trial-derived.
110Unique Sponsors

Conditions

Source: Trial-derived. Crohn's Disease (7)Source: Trial-derived. Gastric Cancer (6)Source: Trial-derived. Multiple Myeloma (6)Source: Trial-derived. Breast Neoplasms (5)Source: Trial-derived. Prostatic Neoplasms (5)Source: Trial-derived. Carcinoma, Renal Cell (4)Source: Trial-derived. Colorectal Neoplasms (4)Source: Trial-derived. Gastroesophageal Junction Adenocarcinoma (4)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (32)Source: Trial-derived. AbbVie (29)Source: Trial-derived. Pfizer (26)Source: Trial-derived. Eli Lilly and Company (13)Source: Trial-derived. Osaka University (13)Source: Trial-derived. Gilead Sciences (11)Source: Trial-derived. Janssen Research & Development, LLC (10)Source: Trial-derived. Amgen (9)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. PET-CT
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. Echocardiography
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. PCR / molecular
Source: AI-inferred. ELISA / immunoassay

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Bone marrow biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Ophthalmological examination
Source: AI-inferred. Visual acuity assessment
Source: AI-inferred. 3D digital skin imaging
Source: AI-inferred. AR LBD mutation testing